ClinicalTrials.Veeva

Menu

Respiratory Functions in Parkinson's Disease

A

Ankara University

Status

Enrolling

Conditions

Parkinson Disease

Study type

Observational

Funder types

Other

Identifiers

NCT07010783
E-59394181-604.01-112206

Details and patient eligibility

About

The aim is to examine respiratory functions, inspiratory muscle strength, respiratory function, physical fitness and aerobic capacity in Parkinson's disease patients. Individuals between the ages of 50-80 who have been diagnosed with Parkinson's disease by a neurologist and healthy individuals with similar demographic characteristics will be included in the study as a control group. In addition, patients will be divided into three groups as above and below 2.5 and healthy controls according to the Modified Hoehn and Yahr Scale. Demographic information of the individuals will be recorded and clinical evaluations will be made. The staging of Parkinson's patients will be done with the Modified Hoehn and Yahr Scale, and the severity of the disease will be done with the Unified Parkinson's Disease Rating Scale. The inspiratory muscle strength of the individuals will be evaluated with the PowerBreath K5, respiratory functions with the Pulmonary Function Test device, and physical fitness and aerobic capacity with the Senior Fitness Test.

Enrollment

100 estimated patients

Sex

All

Ages

50 to 80 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Age 50 to 80
  • Mini Mental State Examination score of 24 to 30
  • Diagnosed with Parkinson's Disease by a neurologist

Exclusion criteria

  • Sözlü iletişim kuramama
  • Yürüme yardımcısı kullanıma
  • Ciddi görme bozukluğu, ek nörolojik bozuklukları ve/veya konjestif kalp yetmezliği olan yaşlılar
  • Egzersiz yapılması tavsiye edilmeyen yaşlı yetişkinler.

Trial design

100 participants in 3 patient groups

Early Stage Patients with Parkinson's Disease
Description:
According to the Modified Hoehn and Yahr Scale (MHÖ), patients with a score below 2.5
Advanced Stage Patients with Parkinson's Disease
Description:
According to the Modified Hoehn and Yahr Scale (MHÖ), patients with 2.5 and above
Control Group
Description:
Healthy individuals with similar demographic characteristics

Trial contacts and locations

1

Loading...

Central trial contact

Büşra Seçkinoğulları Korkusuz, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems